Literature DB >> 31822188

Acute angle closure glaucoma.

Blanca C Flores-Sánchez1, Andrew J Tatham2.   

Abstract

Acute angle closure is an emergent ophthalmic condition that develops as a result of an obstructed outflow of aqueous humour between the anterior and posterior chambers of the eye, leading to a sudden rise in intraocular pressure and secondary optic neuropathy if left untreated. The most common primary cause is a pupillary block in patients with pre-existing narrow angles, such as those who are long-sighted. However, awareness should be raised to identify secondary causes of angle closure, including the use of commonly prescribed medications. A detailed interrogation is essential to exclude other possible confounding disorders that present similarly, especially those originating in the CNS. Angle closure should be excluded in all patients presenting with sudden onset of red eye associated with pupillary dilation, dull pain and headache. Basic examination of the eye should include assessment of the anterior segment with a bright light, measurement of intraocular pressure and a full neurological exam. Immediate treatment must be initiated whenever there is high clinical suspicion of acute angle closure, with the administration of systemic ocular hypotensive therapy to prevent damage to the optic nerve and limit visual loss. An urgent referral to the ophthalmologist is mandatory to dictate definitive management.

Entities:  

Mesh:

Year:  2019        PMID: 31822188     DOI: 10.12968/hmed.2019.80.12.C174

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN: 1750-8460            Impact factor:   0.825


  2 in total

1.  Aqueous humor proteomic analysis of acute angle-closure glaucoma with visual field loss.

Authors:  Jiyu Xu; Liangliang Zhao; Xiang Liu; Haidan Sun; Xiaoyan Liu; Zhengguang Guo; Ying Wang; Wei Sun
Journal:  Ann Transl Med       Date:  2021-11

2.  Peroxisome Proliferator-Activated Receptor α Activation Protects Retinal Ganglion Cells in Ischemia-Reperfusion Retinas.

Authors:  Fei Yao; Xuan Zhang; Xueyan Yao; Xiaohua Ren; Xiaobo Xia; Jian Jiang; Lexi Ding
Journal:  Front Med (Lausanne)       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.